Marshall Wace’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,398
| Closed | -$593K | – | 2572 |
|
|
2024
Q3 | $593K | Buy |
8,398
+2,034
| +32% | +$144K | ﹤0.01% | 1724 |
|
|
2024
Q2 | $422K | Buy |
+6,364
| New | +$422K | ﹤0.01% | 1839 |
|
|
2023
Q2 | – | Sell |
-5,118
| Closed | -$299K | – | 2221 |
|
|
2023
Q1 | $299K | Sell |
5,118
-2,100
| -29% | -$123K | ﹤0.01% | 1821 |
|
|
2022
Q4 | $448K | Sell |
7,218
-1,200
| -14% | -$74.5K | ﹤0.01% | 1848 |
|
|
2022
Q3 | $475K | Buy |
8,418
+4,830
| +135% | +$273K | ﹤0.01% | 2067 |
|
|
2022
Q2 | $229K | Sell |
3,588
-366
| -9% | -$23.4K | ﹤0.01% | 2425 |
|
|
2022
Q1 | $256K | Buy |
3,954
+2,178
| +123% | +$141K | ﹤0.01% | 2309 |
|
|
2021
Q4 | $118K | Buy |
+1,776
| New | +$118K | ﹤0.01% | 2649 |
|